Читать книгу Practical Cardiovascular Medicine - Elias B. Hanna - Страница 72
Initial medical therapy
Оглавление1 69. Schüpke S, Neumann FJ, Menichelli M, et al., on behalf of the ISAR-REACT 5 Trial Investigators. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes. N Engl J Med 2019; 381:1524–34.
2 70. Montalescot G, Bolognese L, Dudek D, et al. Pretreatment with prasugrel in non-ST segment elevation myocardial infarction. N Engl J Med 2013; 369: 999–1010. ACCOAST trial.+Also, SCAAR registry: Dworeck C, Redfors B, Angerås O, et al. Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndromes With Outcomes. JAMA Netw Open. 2020 Oct 1;3(10):e2018735.
3 71. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494–502. CURE trial.
4 72. Hanna EB, Rao SV, Manoukian SV, Saucedo JF. The evolving role of glycoprotein IIb-IIIa inhibitors in the setting of percutaneeous coronary intervention. Strategies to minimize bleeding and improve outcomes. J Am Coll Cardiol 2010; 3: 1209–19.
5 73. Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366: 1622–32. COMMIT-CCS trial.
6 74. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495. +also, for peri-PCI MI reduction: Patti G, Cannon CP, Murphy SA, et al. Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies. Circulation. 2011; 123(15):1622-32.
7 75. Heeschen C, Hamm CW, Laufs U, et al. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 2002; 105: 1446–52.
8 76. Beygui F, Cayla G, Roule V, et al. Early Aldosterone Blockade in Acute Myocardial Infarction. J Am Coll Cardiol. 2016 Apr, 67 (16) 1917–1927. ALBATROSS trial